ouabain and Esophageal Neoplasms

ouabain has been researched along with Esophageal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Folts, CJ; Gao, X; Jiang, M; Lan, X; Lin, S; Liu, K; Lu, R; Noble, MD; Que, J; Zhang, Y; Zhao, T; Zhou, Z1
Hayashi, H; Hazama, S; Hirose, K; lizuka, N; Miyamoto, K; Oka, M; Tangoku, A; Yoshida, H; Yoshimura, K; Yoshino, S1

Other Studies

2 other study(ies) available for ouabain and Esophageal Neoplasms

ArticleYear
Pharmacological targeting of p38 MAP-Kinase 6 (MAP2K6) inhibits the growth of esophageal adenocarcinoma.
    Cellular signalling, 2018, Volume: 51

    Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Cell Proliferation; Digitoxin; Digoxin; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; MAP Kinase Kinase 6; Mice, Inbred NOD; Ouabain; Protein Kinase Inhibitors; Signal Transduction; SOX9 Transcription Factor; Xenograft Model Antitumor Assays

2018
Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase.
    British journal of cancer, 2000, Volume: 83, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cisplatin; DNA; DNA Damage; DNA Fragmentation; DNA, Antisense; DNA, Mitochondrial; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Esophageal Neoplasms; Humans; Monomeric GTP-Binding Proteins; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Ouabain; Sodium-Potassium-Exchanging ATPase; Transcription Factors; Transfection; Tumor Cells, Cultured

2000